Skip to content
Inciteful Med

The Lifelong Journey and Transition to Adulthood

Published: | Updated:

The transition to adulthood with 22q11.2 deletion syndrome involves shifting focus from pediatric development to independence and mental wellness. Key priorities include safely transferring to adult healthcare providers and monitoring for late-onset conditions like Parkinson's and metabolic changes.

Key Takeaways

  • • Medical priorities for 22q11.2DS shift from early childhood development to mental health, metabolic care, and independence in adulthood.
  • • The transition from pediatric to adult healthcare is a vulnerable period that requires proactive planning to avoid dangerous disruptions in routine medical monitoring.
  • • Adults with 22q11.2DS face an increased risk for late-onset conditions, including early-onset Parkinson's disease, autoimmune disorders, and recurrent hypocalcemia.
  • • Mastering daily living skills, such as managing money and transportation, is highly predictive of long-term independence.
  • • Vocational rehabilitation and supported employment programs can significantly help adults with 22q11.2DS thrive in the workplace.

The journey with 22q11.2 deletion syndrome is a lifelong process where medical and developmental needs naturally shift over time. Adulthood brings a new set of clinical priorities focused on independence, mental wellness, and managing late-onset conditions [1][2].

Shifting Priorities Across the Lifespan

  • Infancy & Early Childhood: The primary focus is often on survival and stabilization, including repairing heart defects and managing neonatal calcium levels [3][4].
  • School Age: Priorities shift toward development and communication, such as specialized education (IEPs) and speech therapy [5][6].
  • Adolescence & Adulthood: The focus moves toward mental health and independence, including screening for anxiety or psychosis, managing metabolic health, and planning for independent living [7][8].

The “High-Risk” Transition Period

The move from pediatric to adult healthcare is considered a high-risk time [8]. In the pediatric world, care is often coordinated by a central team. In the adult world, patients are expected to manage their own appointments and navigate a more fragmented system [8][9].

  • Medical Vulnerability: If care is disrupted during this move, important monitoring—like checking calcium levels or psychiatric health—can easily be missed [10][1].

Late-Onset Conditions in Adulthood

Even if an individual was relatively healthy as a child, certain conditions can appear for the first time in adulthood. Knowing what to look for empowers you to act early:

  • Neurological Changes: Adults with 22q11.2DS have an elevated risk for early-onset Parkinson’s disease [11][12].
    • What You Can Do: Inform your doctor if you notice new resting tremors, muscle stiffness, or changes in how you walk. Medications can successfully manage these symptoms.
  • Endocrine & Metabolic Issues: Hypocalcemia can return during stress or illness [13][14]. There is also an increased risk for obesity and metabolic syndrome [15][16].
    • What You Can Do: Maintain an annual check-up that includes a metabolic blood panel and a calcium check.
  • Autoimmune Disorders: Adults may develop new autoimmune issues, where the immune system mistakenly attacks its own tissues [5][17].
    • What You Can Do: Report new, persistent joint pain or extreme fatigue to your primary care doctor.

Pathways to Success and Independence

Success in adulthood looks different for everyone. While a psychiatric diagnosis or an IQ score provides some information, they are not the only factors that determine a person’s future [18].

  • Functional Skills: Research suggests that a person’s daily living skills (like being able to manage money, use transportation, or cook) are highly predictive of independence [19][20].
  • Vocational Support: Many adults with 22q11.2DS succeed in the workplace with the help of vocational rehabilitation or “supported employment” programs that match their unique strengths to the right job environment [8].

With early intervention, proactive care, and strong support networks, individuals with 22q11.2DS can and do lead productive, deeply fulfilling lives well into their senior years [21].

Frequently Asked Questions

When should we start planning the transition to adult care for 22q11.2DS?
You should begin the formal transition planning process early, well before leaving pediatric care. Ask your current doctor when to start this process and for recommendations on adult-oriented specialists who are familiar with 22q11.2 deletion syndrome.
What late-onset adult health conditions should be monitored in 22q?
Adults with 22q11.2 deletion syndrome should be monitored for early-onset Parkinson's disease, returning hypocalcemia, metabolic syndrome, and new autoimmune disorders. Regular check-ups that include a metabolic blood panel and a neurological exam are highly recommended.
Can adults with 22q11.2 deletion syndrome live and work independently?
Yes, with the right support, many adults with 22q11.2DS lead productive and fulfilling lives. Success often depends on developing practical daily living skills and utilizing vocational rehabilitation or supported employment programs to find a suitable work environment.
Why is the transition from pediatric to adult care considered a high-risk time?
The move to adult care is high-risk because the adult system is more fragmented and patients are expected to manage their own appointments. If care is disrupted during this shift, critical monitoring for psychiatric health and calcium levels can easily be missed.

Questions for Your Doctor

  • • When should we begin the formal transition planning process from pediatric to adult specialized care?
  • • Which adult-oriented specialists do you recommend who are familiar with 22q11.2DS or willing to learn?
  • • What specific late-onset adult health screenings (like metabolic panels or neurological exams) should be added to the annual check-up?
  • • What vocational rehabilitation or community support programs do you recommend to aid in the transition to independent living?

Questions for You

  • • What are my long-term goals for work, living arrangements, and social life, and what support do I need to reach them?
  • • How comfortable am I explaining my 22q diagnosis to a new doctor, employer, or friend?
  • • Who are the key people in my support network that I can count on as I take on more responsibility for my own healthcare?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).

    Kuo CY, Signer R, Saitta SC

    Current allergy and asthma reports 2018; (18(12)):75 doi:10.1007/s11882-018-0823-5.

    PMID: 30377837
  2. 2

    22q11.2 deletion syndrome.

    McDonald-McGinn DM, Sullivan KE, Marino B, et al.

    Nature reviews. Disease primers 2015; (1()):15071 doi:10.1038/nrdp.2015.71.

    PMID: 27189754
  3. 3

    Multiple Intestinal Anomalies in a Newborn with 22q11.2 Microdeletion Syndrome: A Case Report and Literature Review.

    Jafar B, Alemayehu H, Bhat R, Zayek M

    Journal of pediatric genetics 2024; (13(3)):237-244 doi:10.1055/s-0042-1750748.

    PMID: 39086451
  4. 4

    Clinical characteristics and immunological status of patients with 22q11.2 deletion syndrome in Northern Thailand.

    Ua-Areechit T, Varnado P, Tengsujaritkul M, et al.

    Asian Pacific journal of allergy and immunology 2023; (41(1)):89-95 doi:10.12932/AP-241019-0671.

    PMID: 32416666
  5. 5

    Risk factors of clinical dysimmune manifestations in a cohort of 86 children with 22q11.2 deletion syndrome: A retrospective study in France.

    Mahé P, Nagot N, Portales P, et al.

    American journal of medical genetics. Part A 2019; (179(11)):2207-2213 doi:10.1002/ajmg.a.61336.

    PMID: 31471951
  6. 6

    Defining Risk of Postoperative Obstructive Sleep Apnea in Patients With 22q11.2DS Undergoing Pharyngeal Flap Surgery for Velopharyngeal Dysfunction Using Polysomnographic Evaluation.

    Lee A, Chang BL, Solot C, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2020; (57(7)):808-818 doi:10.1177/1055665619900871.

    PMID: 31973553
  7. 7

    The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome.

    Chawner SJRA, Niarchou M, Doherty JL, et al.

    Journal of psychiatric research 2019; (109()):10-17 doi:10.1016/j.jpsychires.2018.11.002.

    PMID: 30458299
  8. 8

    Healthcare Transition to Adulthood in Patients with 22q11.2 Deletion Syndrome: A Comprehensive Literature Review and Transition Framework.

    MacIsaac MF, Mattia A, Montes LA, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2025; 10556656251331392 doi:10.1177/10556656251331392.

    PMID: 40223294
  9. 9

    Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.

    Karbarz M

    Genes 2020; (11(9)) doi:10.3390/genes11090977.

    PMID: 32842603
  10. 10

    Surgical insights and management in patients with the 22q11.2 deletion syndrome.

    McGovern PE, Crowley TB, Zackai EH, et al.

    Pediatric surgery international 2022; (38(6)):899-905 doi:10.1007/s00383-022-05123-0.

    PMID: 35411495
  11. 11

    22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

    Boot E, Bassett AS, Marras C

    Movement disorders clinical practice 2019; (6(1)):11-16 doi:10.1002/mdc3.12687.

    PMID: 30746410
  12. 12

    Neurological manifestation of 22q11.2 deletion syndrome.

    Bayat M, Bayat A

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):1695-1700 doi:10.1007/s10072-021-05825-8.

    PMID: 35039989
  13. 13

    Hypocalcemia due to 22q11.2 deletion syndrome diagnosed in adulthood.

    Cabrer M, Serra G, Gogorza MS, Pereg V

    Endocrinology, diabetes & metabolism case reports 2018; (2018()) doi:10.1530/EDM-17-0140.

    PMID: 29340157
  14. 14

    Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult.

    van der Meijs ME, Schweitzer DH, Boom H

    European journal of case reports in internal medicine 2021; (8(4)):002411 doi:10.12890/2021_002411.

    PMID: 33987118
  15. 15

    Obesity and metabolic syndrome in adults with a 22q11.2 microdeletion.

    Jaspers Faijer-Westerink H, von Scheibler ENMM, van Rossum EFC, et al.

    International journal of obesity (2005) 2025; (49(4)):642-648 doi:10.1038/s41366-024-01685-2.

    PMID: 39616274
  16. 16

    Understanding obesity in children with 22q11.2 deletion syndrome.

    Sarli WM, Cerutti M, Pontone M, et al.

    Frontiers in endocrinology 2025; (16()):1628796 doi:10.3389/fendo.2025.1628796.

    PMID: 40822943
  17. 17

    Lymphoproliferative disorder with polyautoimmunity and hypogammaglobulinemia: An unusual presentation of 22q11.2 deletion syndrome.

    Soares DC, Dantas AG, Matta MC, et al.

    Clinical immunology (Orlando, Fla.) 2020; (220()):108590 doi:10.1016/j.clim.2020.108590.

    PMID: 32920211
  18. 18

    Variability in Neuropsychological Phenotypes in Patients with 22Q11.2 Deletion Syndrome: Case Series.

    Wierzchowski A, Sablich-Duley S, Bordes Edgar V

    Developmental neuropsychology 2021; (46(5)):381-392 doi:10.1080/87565641.2021.1956498.

    PMID: 34311629
  19. 19

    Adaptive living skills, sleep problems, and mental health disorders in adults with 22q11.21 deletion syndrome.

    Leader G, Curtin A, Shprintzen RJ, et al.

    Research in developmental disabilities 2023; (136()):104491 doi:10.1016/j.ridd.2023.104491.

    PMID: 36965410
  20. 20

    The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.

    Swillen A

    Current opinion in psychiatry 2016; (29(2)):133-7 doi:10.1097/YCO.0000000000000231.

    PMID: 26779858
  21. 21

    Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.

    Moberg PJ, Richman MJ, Roalf DR, et al.

    Behavior genetics 2018; (48(4)):259-270 doi:10.1007/s10519-018-9903-5.

    PMID: 29922984

This page provides educational information about transitioning to adult care with 22q11.2 deletion syndrome. Always consult your healthcare team for personalized medical advice and structured transition planning.

Stay up to date

Get notified when new research about 22q11.2 deletion syndrome is published.

No spam. Unsubscribe anytime.